Horton D R INC /DE/ Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Vanguard Capital Management has reported a 6.86% beneficial ownership stake in homebuilder D.R. Horton Inc.
NYSE
The Vanguard Group reports zero beneficial ownership in DR Horton Inc. common stock following an internal realignment effective January 12, 2026.
NYSE
Capital World Investors reported an increased beneficial ownership of 12.8% in D.R. Horton, Inc. common stock.
NYSE
Capital World Investors has reported a 10.2% beneficial ownership stake in D.R. Horton, Inc., holding over 30 million shares of common stock.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 3.9% beneficial ownership stake in D.R. Horton, Inc. as of May 30, 2025.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 5.2% Stake in D.R. Horton, Inc.
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a beneficial ownership of 5.2% in D.R. Horton, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reaffirming its significant 9.0% beneficial ownership stake in D.R. Horton, Inc. common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: Horton Family Entities and Executives Maintain Significant Stake in D.R. Horton, Inc.
An amended Schedule 13G filing reveals that key Horton family members and their associated entities continue to hold substantial beneficial ownership in D.R. Horton, Inc., reinforcing insider alignment.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting a 6.4% passive beneficial ownership stake in DR Horton Inc. as of December 31, 2024.